AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

Support for the Dental and Optometric Care (DOC) Access Act (HR 1521), which would prohibit dental and vision plans from capping fees on non-covered services Support for reintroduction of the Ensuring Lasting Smiles Act (S 1677/HR 3277), which would require health insurers to cover treatment, including dental, for patients with congenital craniofacial anomalies.

Support for the Resident Education Deferred (REDI) Act (HR 2028/S 942), which would allow physicians and dentists to defer their student loans interest free during residency. Input to the Department of Education regarding implementation of student loan provisions from the One Big Beautiful Bill Act (OBBB). Concerns to the U.S. Department of Education regarding proposed rulemaking on the Public Service Loan Forgiveness (PSLF) program that seeks to bar organizations from participating in the PSLF program if they engage in activities that have a substantial illegal purpose.

Support for H.R. 879, the bipartisan Medicare Patient Access and Practice Stabilization Act, which would halt the 2.83 percent Medicare physician payment cut and provide a 6.62 percent update through the end of the year to address inflationary pressures.

Support for the RAPID Reserve Act (S 2062/HR 3955), which aims to address drug shortages by awarding federal contracts to American-based manufacturers of generic drugs to encourage domestic production of these critical medications as well as incentivize them to increase their reserves in preparation for possible future public health threats or supply chain challenges and ramp up their production capacity if necessary to proactively prevent shortages. Support for the Mapping Americas Pharmaceutical Supply or MAPS Act (S 1784/HR 4191), which seeks conduct a risk assessment and supply chain map of all essential medicines to help identify vulnerabilities and potential national security risks. Support for the reintroduction of the following drug and supply bills from the 118th Congress: The Drug Shortages Prevention and Quality Improvement Act, which aimed to implement reimbursement models to incentivize the production of generic injectables and extend expiration dates for lifesaving medications. Suggestions for deregulation within federal healthcare programs, specifically the request to Rescind Limitations on Notice and Consent Waivers for Non-Emergency Services under the No Surprises Act and to Streamline or Eliminate the Merit-based Incentive Payment System (MIPS). Comments to CMS expressing concern about implementation of the Non-Opioids Prevent Addiction in the Nation ("NOPAIN") Act as provided for in the CY 2026 Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems Proposed Rule. Support for HR 4556, the the Protect Our Treatment for Enamel, Erosion, and Tooth Health (TEETH Act), which would require the Environmental Protection Agency (EPA) to commission an independent, rapid-response evidence review from the National Academies of Sciences, Engineering, and Medicine before proposing updates to drinking water regulations that affect community water fluoridation.